[1] 南京中医药大学.中药大辞典[M].2版.上海:上海科技出版社,2006:1998. [2] 李晋玉,赵学千,孙旗,等.骨碎补总黄酮的实验及临床研究概况[J].中国骨质疏松杂志,2018,24(10):1357-1364. [3] 陈海啸,梁军波,伍海昭.骨碎补总黄酮对去卵巢大鼠腰椎松质骨骨形态计量学参数的影响[J].中医正骨,2011,23(4):18-20. [4] 常安瑾,钱莹,陈晓农,等.维持性血液透析患者不同骨转换类型下松质骨微观结构的研究[J].中国血液净化,2017,16(1):48-53. [5] 杨瑾廷,韩向龙.骨组织血管系统中血管形成与骨形成的偶联效应[J].中国组织工程研究,2017,21(36):(23): 5855-5861. [6] ZHU S P,BENNETT S,KUEK V,et al.Endothelial cells produce angiocrine factors to regulate bone and cartilage via versatile mechanisms[J].Theranostics,2020,10(13):5957-5965. [7] 上官文姬,李展春,程光齐,等.骨碎补总黄酮对血管内皮细胞功能和去卵巢大鼠血管形成的影响[J].中国中医骨伤科杂志,2017,25(1):5-8,13. [8] NAN S,ZHAO Z H,MA X L,et al.Naringin promotes fracture healing through stimulation of angiogenesis by regulating the VEGF/VEGFR-2 signaling pathway in osteoporotic rats[J].Chemico-Biological Interactions,2017,261:11-17. [9] 上官文姬,李鹤,汤璐敏.骨碎补总黄酮对大鼠成骨细胞VEGF和FGF-2表达的影响[J].辽宁中医药大学学报,2014,16(8):38-41. [10] 童安莉,陈璐璐,丁桂芝.成骨细胞骨形成机制研究进展[J].中国骨质疏松杂志,1999(3):3-5. [11] 盛华刚. 骨碎补对成骨细胞和破骨细胞作用的研究进展[J].化工时刊,2013,27(5):38-40. [12] 张军,李浩鹏,杨平林,等.骨碎补总黄酮含药血清对成骨细胞增殖、分化、周期及凋亡的影响[J].中药材,2009,32(7):1090-1093. [13] 黎小坚,HAROLD M F,朱绍舜,等.基础骨生物学新观[J].中国骨质疏松杂志,2001(2):59-81. [14] LI F B,SUN X B,MA J X,et al.Naringin prevents ovariectomy-induced osteoporosis and promotes osteoclasts apoptosis through the mitochondria-mediated apoptosis pathway[J].Biochemical and Biophysical Research Communications,2014,452(3):629-635. [15] 李思维,王静,陈林,等.维生素D与骨关节炎[J].中华关节外科杂志(电子版),2018,12(1):96-101. [16] 李冬霞,陈颖颖,罗静,等.骨碎补总黄酮干预骨关节炎机制的研究进展[J].风湿病与关节炎,2019,8(3):66-69. [17] 刘乐平,刘慧萍,谢瑾如,等.壮骨止痛方有效成分关联分析[J].中草药,2018,49(6):1451-1460. [18] HANG K,YE C Y,XU J X,et al.Apelin enhances the osteogenic differentiation of human bone marrow mesenchymal stem cells partly through Wnt/β-catenin signaling pathway[J].Stem Cell Research and Therapy,2019,10(1):189. [19] MURALIDHAR S,FILIA A,NSENGIMANA J,et al.Vitamin D-VDR signaling inhibits Wnt/β-Catenin-mediated melanoma progression and promotes antitumor immunity[J].Cancer Research,2019,79(23):5986-5998. [20] LI Q Y,LAI Q H,HE C C,et al.RUNX1 promotes tumour metastasis by activating the Wnt/β-catenin signalling pathway and EMT in colorectal cancer[J].Journal of Experimental and Clinical Cancer Research,2019,38(1):334. [21] PING Z C,HU X Y,WANG L L,et al.Melatonin attenuates titanium particle-induced osteolysis via activation of Wnt/β-catenin signaling pathway[J].Acta Biomaterialia,2017,51:513-525. [22] QI H H,BAO J,ZHANG Q,et al.Wnt/β-catenin signaling plays an important role in the protective effects of FDP-Sr against oxidative stress induced apoptosis in MC3T3-E1 cell[J].Bioorganic and Medicinal Chemistry Letters,2016,26(19):4720-4723. [23] 胡中青,汤样华,曾林如,等.右归丸治疗骨质疏松性骨缺损的机制研究[J].中国中医骨伤科杂志,2018, 26(7):11-15,20. [24] TOSHIHISA K.Regulation of bone development and extracellular matrix protein genes by RUNX2[J].Cell and Tissue Research,2010,339(1):189-195. [25] 李晋玉,俞兴,姜俊杰,等.骨碎补总黄酮联合纳米骨材料促进MC3T3-E1细胞的增殖分化[J].中国组织工程研究,2020,24(7):1030-1036. [26] 陈世海,谢兴文,李建国,等.Wnt/β-catenin信号通路在补肾中药靶向治疗骨质疏松症中应用的研究进展[J].中国骨质疏松杂志, 2019, 25(4):559-563. [27] LV J W,SUN X L,MA J X,et al.Involvement of periostin-sclerostin-Wnt/β-catenin signaling pathway in the prevention of neurectomy-induced bone loss by naringin[J].Biochemical and Biophysical Research Communications,2015,468(4):587-593. [28] ATSUHIKO H,IKUO Y,WAKEYAMA H,et al.Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand[J].The Journal of Biological Chemistry,2006,281(48):36846-36855. [29] LI J,SUN Z Y,LIN Y,et al.Syndecan 4 contributes to osteoclast differentiation induced by RANKL through enhancing autophagy[J]. International Journal of Immunopharmacology, 2021,91:107275. [30] MOHAMMAD T,MOHAMMED H M,AMIN N,et al.RANKL/RANK/OPG pathway: a mechanism involved in exercise-induced bone remodeling[J].BioMed Research International,2020,2020:6910312. [31] 曾辉,赵许兵,唐成芳,等.骨碎补总黄酮对去卵巢大鼠下颌骨结构、血清E2及OPG/RANKL的影响[J].西安交通大学学报(医学版),2019,40(2):328-332. [32] 肖亚平,曾杰,焦琳娜,等.补肾中药对骨质疏松症的治疗及其信号通路调节作用的研究进展[J].中国中药杂志,2018,43(1):21-30. [33] 施彦龙,李应福,谢兴文,等.BMP-Smads、OPG/RANK/RANKL信号通路与骨质疏松关系的研究进展[J].中国骨质疏松杂志,2020,26(4):600-604. [34] 庞新岗,李永刚,包倪荣,等.骨代谢主要信号通路及信号分子的研究进展[J].基础医学与临床,2018,38(12):1799-1803. [35] 王庆丰,王孝辉,张彩丽,等.骨碎补总黄酮促进大鼠诱导膜中VEGF、BMP-2表达的实验研究[J].药物评价研究,2018,41(7):1220-1223. [36] 姜自伟,曾景奇,李悦,等.骨碎补总黄酮对大鼠胫骨牵张末期BMP-2与Smad-1表达的影响[J].辽宁中医杂志,2018,45(1):166-168,227. [37] 沈智,曾景奇,李益亮,等.骨碎补总黄酮对悬尾实验性骨质疏松模型大鼠骨密度及BMP-2 mRNA的影响[J].中医药导报,2019,25(21):33-36. [38] WU J B, FONG Y C, TSAI H Y, et al.Naringin-induced bone morphogenetic protein-2 expression via PI3K,Akt,c-Fos/c-Jun and AP-1 pathway in osteoblasts[J].European Journal of Pharmacology,2008,588(2/3):333-341. [39] 丁祎,崔宇,张令强.调控骨骼形成的信号通路[J].中国生物化学与分子生物学报,2021,37(4):428-436. [40] WU X,CHEN S,ORLANDO S A,et al.p85alpha regulates osteoblast differentiation by cross-talking with the MAPK pathway[J].Journal of Biological Chemistry,2011,286(15):13512-13521. [41] 尹文哲,邢成亮,王建业,等.失重下骨碎补总黄酮经ERK通路促成骨细胞增殖研究[J].中医药学报,2017,45(5):45-48. [42] 张力,徐勃兴,李杰,等.MAPK抑制剂对骨碎补总黄酮促进转基因成肌细胞成骨分化的影响[J].中国组织工程研究,2016,20(51):7622-7627. [43] 邓传超,尹文哲,杜挺媛,等.失重下骨碎补总黄酮经JNK通路促成骨细胞增殖研究[J].哈尔滨医科大学学报,2016,50(5):403-406. [44] 王丹华. 仙灵骨葆胶囊中组织蛋白酶K靶向性抗骨质疏松化学成分筛选[J].中华骨质疏松和骨矿盐疾病杂志,2019,12(5):488-493. [45] 史晓林,李春雯,孙金谞,等.骨碎补总黄酮对去卵巢大鼠组织蛋白酶K的影响[J].中华骨质疏松和骨矿盐疾病杂志,2010,3(4):285-290. [46] 周灵通,黄凯,宋敏,等.Notch信号通路在骨重建过程中的双向调节作用[J].中国骨质疏松杂志,2019,25(7):1015-1020. [47] 韩亚力,罗奕,曾佳学.骨碎补总黄酮基于Notch信号通路改善骨质疏松的作用及机制研究[J].中国免疫学杂志,2018,34(2):261-266. [48] 方霁,杨丽,沈家珍,等.骨碎补总黄酮对去卵巢骨质疏松大鼠骨内谷氨酸信号Glu、mGluR5以及EAAT_1的影响[J].中国生化药物杂志,2014,34(2):10-12,16. [49] 吕辰鹏. 骨碎补总黄酮对去卵巢大鼠骨组织GABA信号通路的影响[D].广州:暨南大学,2011. [50] 曾强成,张西正,刘洪玲,等.谷氨酸信号通路及其在骨力学信号转导通路中潜在的功能[J].生物技术通讯,2007(5):827-829. |